« Previous
Next »
Reproductive BioMedicine Online
Volume 20, Issue 2
, Pages 223-233
, February 2010
Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos
References
- Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 1999;189:1149–1156
- Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction. 2006;131:583–589
- . HLA Class I protein expression in the human placenta. Early Pregnancy. 2001;5:67–69
- Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur. J. Immunol. 1997;27:3380–3388
- Passive immunization against the MHC class I molecule Mamu-AG disrupts rhesus placental development and endometrial responses. J. Immunol. 2007;179:8042–8050
- Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998;187:813–818
- Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts. Placenta. 2007;28:383–389
- Human trophoblast adhesion to matrix proteins: inhibition and signal transduction. Hum. Reprod. 1995;10:2489–2500
- Search for a human homologue of the mouse Ped gene. Mol. Hum. Reprod. 1999;5:541–547
- Trogocytosis-based generation of suppressive NK cells. EMBO J. 2007;26:1423–1433
- Evidence that HLA-G is the functional homolog of mouse Qa-2, the Ped gene product. Hum. Immunol. 2003;64:999–1004
- . Spatio-temporal localization of membrane lipid rafts in mouse oocytes and cleaving preimplantation embryos. Dev. Biol. 2007;303:727–739
- Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood. 2007;109:2806–2814
- . Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J. Immunol. 1990;144:731–735
- . Killing of mouse blastocyst stage embryos by cytotoxic T lymphocytes directed to major histocompatibility complex antigens. J. Immunol. 1987;138:2764–2770
- Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood. 2006;108:2608–2615
- HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur. J. Immunol. 2002;32:311–315
- The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J. Immunol. 2005;175:4866–4874
- . The role of dydrogesterone in recurrent (habitual) abortion. J. Steroid Biochem. Mol. Biol. 2005;97:426–430
- . Maternal acceptance of the fetus: true human tolerance. J. Immunol. 2007;178:3345–3351
- Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 2003;171:1376–1384
- HLA-G expression during preimplantation human embryo development. Proc. Natl. Acad. Sci. USA. 1996;93:161–165
- HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 2000;30:1623–1631
- A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248:220–223
- . Commentary. Major breakthrough in the HLA-G debate: occurrence of pregnancy in human depends on the HLA-G status of preimplantation embryos. Eur. J. Immunol. 2002;32:309–310
- HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 1998;95:5199–5204
- Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens. 2003;62:273–284
- HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 1998;28:2854–2863
- . How does the maternal immune system contribute to the development of pre-eclampsia?. Placenta. 2007;28(Suppl. A):S51–S56
- . Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal–maternal interface. Biol. Reprod. 2002;67:1375–1378
- Detecting and quantifying colocalization of cell surface molecules by single particle fluorescence imaging. Biophys. J. 2003;85:4110–4121
- The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 1999;29:277–283
- Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies. Eur. J. Immunol. 1991;21:2121–2131
- Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem. Biophys. Res. Commun. 2004;313:606–611
- The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol. Hum. Reprod. 2001;7:373–378
- . Quantitative grading of a human blastocyst: optimal inner cell mass size and shape. Fertil. Steril. 2001;76:1157–1167
- HLA-G inhibits the allogeneic proliferative response. J. Reprod. Immunol. 1999;43:203–211
- . MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 2005;5:459–471
- The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line. Immunogenetics. 2004;56:617–624
- . Cell–cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts. J. Exp. Med. 1991;174:737–740
- Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J. Immunol. 2008;180:4330–4337
- . Pre-implantation mouse embryos express mhc class I genes before the first cleavage division. Immunogenetics. 1993;38:35–40
- In-vitro attachment of bovine hatched blastocysts on fibronectin is mediated by integrin in a RGD dependent manner. J. Reprod. Dev. 2005;51:47–57
- . Influence of maternal age on the outcome of PGD for aneuploidy screening in patients with recurrent implantation failure. Reprod. Biomed. Online. 2005;10:628–632
- . HLA-E and immunobiology of pregnancy. Tissue Antigens. 2006;67:207–213
- . Human uterine leukocytes and pregnancy. Tissue Antigens. 2004;63:1–12
- Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol. Hum. Reprod. 2007;13:123–133
- Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol. Hum. Reprod. 2004;10:189–195
- . Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum. Reprod. Update. 2008;14:209–218
- . Analysis of litter size and weight in mice differing in Ped gene phenotype and the Q region of the H-2 complex. J. Reprod. Immunol. 1991;19:303–313
- . Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation-embryo-development (Ped) gene product. Biol. Reprod. 1987;36:611–616
- . Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J. Immunol. 2005;175:8379–8385
- Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum. Reprod. 2006;21:46–51
Valerie Shaikly graduated with a BSc Honors degree in life sciences from the University York in 1990. She then began training as a clinical embryologist at the Hammersmith Hospital, London. Whilst working as a senior embryologist she completed a Master’s degree in health promotion in infertility at the University of East London. Valerie began her research in reproductive immunology whilst working as a senior embryologist at the Assisted Reproduction and Gynaecology Centre, London. In 2009, she was awarded a PhD from the University of Essex. Her research has focused on the investigation of factors associated with human preimplantation embryo development and foetal maternal tolerance during the course of in-vitro fertilisation.
PII: S1472-6483(09)00221-1
doi: 10.1016/j.rbmo.2009.11.008
© 2010 Reproductive Healthcare Ltd. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Reproductive BioMedicine Online
Volume 20, Issue 2
, Pages 223-233
, February 2010
